Category: News

Dr. Queen is recognized for years of innovative research and outstanding clinical care. She has been actively involved with the Thurston Arthritis Research Center in many different roles, and has repeatedly demonstrated outstanding research acumen as well as a passion for helping patients

Learn how Thurston scientists are helping the medical community better understand diseases such as meat allergy, lupus, and osteoarthritis in new ways, thanks to cutting edge research and important new insights.

Under TARC’s leadership, the Alliance has doubled its membership and initiated a number of innovative programs and resources for patients and clinicians.

Leading researcher provides valuable insights into causes and impact of physical inactivity.

Thurston scientists are leading the way in studying the cause and geographical spread of a meat allergy related to tick bites, novel ways to treat a variety food allergies, addressing barriers to immunizations, novel exercise interventions for osteoarthritis, and new tools that are important to genomics research.

Learn about our exciting leadership changes, and get the latest updates regarding research and treatment of rheumatologic, allergy and immunologic diseases.

Researchers are conducting basic, epidemiological, and clinical research designed to shed important new insights into this poorly understood but often serious disease.

Findings might help scientists develop novel and individualized patient therapies.

This research is the first to clearly identify and illuminate a specific mechanism of action involved in lupus. Funding from the Lupus Research Institute is helping pave the way for additional research, and TARC has begun enrolling patients for a clinical trial designed provide additional insights into this disease.

This research is the first to clearly identify and illuminate a specific mechanism of action involved in lupus. Funding from the Lupus Research Institute is helping pave the way for additional research, and TARC has begun enrolling patients for a clinical trial designed provide additional insights into this disease.